Real-world effectiveness of 20-valent pneumococcal conjugate vaccine against all-cause outcomes among Medicare beneficiaries aged 65 years and older in the USA: a retrospective cohort study. (linkinghub.elsevier.com)

Authors: Miles AC … Cane A Journal: Lancet Infectious Diseases Published: 2026-04-30 DOI: https://doi.org/10.1016/S1473-3099(26)00115-5